Results 161 to 170 of about 377,857 (257)

Bleomycin-Electrosclerotherapy in the treatment of superficial slow-flow vascular malformations of head and neck. [PDF]

Front Neurol
Obereisenbuchner F, Seebauer CT, Borisch E, Puhr-Westerheide D, Deniz S, Sint A, Platz Batista da Silva N, Vielsmeier V, Kühnel T, Vollbach FH, Haehl J, Hartl A, Wohlgemuth WA, Ricke J, Seidensticker M, Wildgruber M, Schmidt VF.   +16 more
europepmc   +1 more source

Air Pollution and the Risk and Progression of Multiple Sclerosis: A Systematic Review and Meta‐Analysis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Purpose Air pollution has been linked to several neurological conditions, including stroke and neurodegenerative diseases. Evidence regarding its association with multiple sclerosis (MS) remains conflicting, limited by small sample sizes. Methods PubMed, Embase, Scopus, and Cochrane controlled register of trials (CENTRAL) were searched on ...
Ahmad A. Toubasi, Thuraya N. Al‐Sayegh
wiley   +1 more source

Outcomes of Slow-Absorbable Biosynthetic Mesh (Phasix™) in Hernia Repair at Tertiary Care Center, Riyadh, Saudi Arabia. [PDF]

Healthcare (Basel)
Al Babtain I, Almalki S, Alwabel W, Alhoumaily B, Albaqami G, Aldawsari S, Alorf K.   +6 more
europepmc   +1 more source

Validity of a Wearable Digital Insole for Assessing Gait ON and OFF in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Gait impairment is a distinctive symptom of Parkinson's disease that negatively impact mobility. We assessed the validity of wearable digital insoles against a validated reference gait analysis system for measuring select gait characteristics in patients with Parkinson's disease. Methods A comparative analysis between digital insoles
Deborah A. Hall, Kimberly Kwei, Rolando J. Acosta, Bharatkumar Koyani, Erin Robertson, Pratyush Rai, Roland Barge, Emily Timm, Nicollette L. Purcell, Natasha Desai, Dhanesh Patel, Ana‐Maria Visoiu‐Knapp, Samuel Stuart, Rinol Alaj, Matthew F. Wipperman, Oren Levy, Joan A. O'Keefe   +16 more
wiley   +1 more source

Isokinetic dynamometry assessment of the transition period between eccentric and concentric hamstring contractions in athletes with a history of hamstring injury. [PDF]

Front Rehabil Sci
Vincent B, Perla F, Neuillet J, Page A, Caquant M, Schiller A.   +5 more
europepmc   +1 more source

Baseline Regional Cholinergic Denervation Predicts Cognitive Trajectories in Moderate Parkinson Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cognitive decline is a disabling and variable feature of Parkinson disease (PD). While cholinergic system degeneration is linked to cognitive impairments in PD, most prior research reported cross‐sectional associations. We aimed to fill this gap by investigating whether baseline regional cerebral vesicular acetylcholine transporter ...
Taylor Brown, Giulia Carli, Prabesh Kanel, Stiven Roytman, Jaimie Barr, Nicolaas I. Bohnen, Roger L. Albin   +6 more
wiley   +1 more source

The Proteo-Transcriptome of Extracellular Vesicles and Particles Is Largely Preserved After Cryopreservation. [PDF]

J Extracell Biol
Nose Y, Del Valle DM, Gonsalves TR, Tuballes K, Ellis E, Xie H, Figueiredo I, Guo R, Chandra A, Hahn A, Korrapati A, Ioannou G, Cabal R, Tichkule S, Fullard JF, Roussos P, Silva P, Amabile A, Morgenroth-Rebin J, Dawson T, Merand R, Nie K, Chen Z, Nirenberg S, Brown B, Kim-Schulze S, Kaufman A, Flores R, Zuluaga L, Beaumont K, Sebra R, Kyprianou N, Attalla K, Badani K, Tewari A, Dogra N, Gnjatic S, Gonzalez-Kozlova E.   +37 more
europepmc   +1 more source

A Prospective Study of Individuals at Risk of Multiple Sclerosis Informs the Design of Primary Prevention Studies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective In multiple sclerosis, the optimal time for deploying a therapeutic intervention is before the central nervous system is damaged; given the success of trials treating the earliest stage of MS, the radiologically isolated syndrome, developing primary prevention strategies is an important next challenge.
Amy W. Laitinen, Ceren Tozlu, Tina Roostaei, Fatoumata Diallo, Kaho Onomichi, Jiyeon Son, Zongqi Xia, Philip L. De Jager   +7 more
wiley   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane, Giorgia Coratti, Chiara Cutrì, Antonio Varone, Riccardo Masson, Adele D'Amico, Valeria Sansone, Sonia Messina, Federica Ricci, Chiara Ticci, Claudio Bruno, Caterina Agosto, Francesca Benedetti, Antonella Pini, Sabrina Siliquini, Massimiliano Filosto, Alberto Zambon, Ilaria Bitetti, Maria Rosaria Manna, Claudia Dosi, Riccardo Zanin, Stefano Parravicini, Roberto De Sanctis, Giulia Stanca, Michela Catteruccia, Michele Tosi, Irene Mizzoni, Emilio Albamonte, Valentina Franchino, Maria Sframeli, Ilaria Cavallina, Elena Procopio, Michele Sacchini, Simone Morando, Noemi Brolatti, Federica Trucco, Gaia Scarpini, Elena Briganti, Beatrice Berti, Concetta Palermo, Daniela Leone, Stefano C. Previtali, Eugenio Mercuri, the ITASMAC working group   +43 more
wiley   +1 more source